Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both

Journal article

Peer reviewed

Marc P Bonaca, Javid J Moslehi, Jonathan A Ledermann, Elisabete Michelon, Caimiao Wei, Michael Moran, Bradley J Monk and Eric Pujade-Lauraine

The oncologist (Dayton, Ohio)

09/04/2023

Metrics

1 Record Views

Title: Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both
Creators: Marc P Bonaca - University of Colorado Denver
Javid J Moslehi - Cardiovascular Institute of the South
Jonathan A Ledermann - CRUK Lung Cancer Centre of Excellence
Elisabete Michelon - Pfizer
Caimiao Wei - Pfizer
Michael Moran - Pfizer
Bradley J Monk - The US Oncology Network
Eric Pujade-Lauraine - Arcagy Gineco
Publication Details: The oncologist (Dayton, Ohio)
Identifiers: 991006037469102656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article